In this Q&A, Avihu Tamir, CEO of Kanabo Group, the Israeli-based medicinal cannabis firm, which earlier this year made its debut on London’s main market, discusses the company’s milestones since August 2021 – from new partnerships and new formulas, to new licence facilities and efficacy trials – and how the cannabis market continues to evolve in Europ

source